Health & biology · June 2026
Implanted speech BCI trial
The first FDA-approved trial of a fully implanted speech prosthesis begins.
Surgeons at University of Michigan Health implanted Paradromics' 421-electrode Connexus device in a woman with motor neuron disease, the first patient in the Connect-One trial to restore speech with a fully implanted brain-computer interface.